-
Seer, Inc. (SEER) Misses Q3 EPS by 1c
-
Seer to present proteomics research at genetics conference
-
Seer, Inc. (SEER) Tops Q2 EPS by 3c
-
Seer, Inc. (SEER) Launches New Proteograph Workflow
-
Seer, Inc. (SEER) Tops Q1 EPS by 3c
-
TD Cowen: 'Top 10 Themes Coming Out of 45th Annual Health Care Conference'
-
Seer, Inc. (SEER) Reports In-Line Q4 EPS
-
TD Cowen: 'Assessing Impact of US Ban on China Exports for LCMS & Flow Cyt Instruments'
-
Seer, Inc. (SEER) Misses Q3 EPS by 4c
-
Seer, Inc. (SEER) Appoints Nicolas Roelofs to its Board
-
Seer, Inc. (SEER) Announces Resignation of Chief Legal Officer
-
Seer (SEER) Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discover

